Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 71 for “"PPARgamma"”.
-
PPARgamma-Polymorphismus (Pro12Ala)
… häufig auftretenden Pro 12 Ala Mutation in PPARgamma auf das Körpergewichtund den Gewichtsverlauf nach gastric banding Operationen untersucht haben. Weiter untersuchten wir Parameter des Glukosestoffwechsels (Glukose, Insulin, C-Peptid). PPARs sind transkriptionelle Regulatoren der …
-
Regulation of Adipocyte Transcription by PPARgamma Ligands
… Rosi functions as a high-affinity ligand for PPARgamma, the adipocyte-predominant nuclear receptor (NR). The classic model of NR action, involving binding of ligand to the NR on DNA, explains positive regulation of gene expression, but both ligand-dependent transcriptional repression and …
-
Regulation of PPARgamma Activity by mTOR in Adipogenesis
… feedback loop between C/EBPalpha and PPARgamma. The PPARgamma activity toward its target genes was specifically inhibited by rapamycin upon insulin stimulation. I demonstrate that PPARgamma activity is dependent on amino acid sufficiency, revealing a molecular link between nutrient …
-
Identifizierung und Charakterisierung von AT1-Antagonisten als PPARgamma Liganden
… Proliferator Aktivierte Rezeptor gamma (PPARgamma) spielt eine wichtige Rolle im Glukose- und Lipidstoffwechsel. Synthetische Liganden für PPARgamma, die Thiazolidindione, besitzen eine insulinsensitivierende Wirkung und können die Entstehung und Progression von Typ-II- Diabetes …
-
The Protective Role of PPARgamma in Pulmonary Arterial Hypertension
… proliferator-activated receptor gamma (PPARgamma) and its transcriptional target apolipoprotein E (apoE). BMP-2/BMP-RII signaling prevented PDGF-BB-induced proliferation of human and murine pulmonary artery smooth muscle cells (PASMC), by decreasing nuclear phosphoERK and inducing …
-
Immunregulatorische Mechanismen des nukleären PPARgamma-Rezeptors bei atopischer Dermatitis
Die atopische Dermatitis (AD) ist eine chronisch entzündliche, mit ausgeprägtem Juckreiz einhergehende Hautkrankheit. Sie resultiert aus dem Zusammenspiel genetischer, immunologischer und umweltbedingter Faktoren. Unsere Arbeitsgruppe konnte in vorangegangenen Untersuchungen zeigen, dass …
-
The role of retinaldehyde and PPARgamma signaling in systemic lupus erythematosus
… by our lab have shown beneficial effects of PPARgamma agonists towards preventing SLE in two different mouse models: the well-established lupus mouse model, MRL.lpr, and the gld.apoE^-/- model of accelerated lupus and atherosclerosis. Retinaldehyde is a retinoic acid precursor that has …
-
Modulation of Coronary Reactive Hyperemia through Soluble Epoxide Hydrolase: Role of Oxylipins and PPARgamma
… among sEH, CYP-epoxygenase pathway, oxylipins, PPARgamma, and CRH response to a brief ischemia is not known. We hypothesized that targeting sEH, by pharmacologic inhibition or genetic deletion, enhances CRH in isolated mouse hearts through changing the oxylipin profiles, including an increase in …
-
The impact of environmental metabolic disruptors on PPARgamma transcriptional regulation of adipocyte differentiation and function
Metabolic homeostasis is controlled, in part, by a family of proteins called nuclear receptors through which lipophilic hormones and hormone-like molecules regulate gene expression. One such nuclear receptor is peroxisome proliferator activated receptor γ (PPARγ). Its activation is essential for …
-
IDENTIFICATION OF A NOVEL SMALL-MOLECULE PPARGAMMA ACTIVATOR THAT INDUCES AUTOPHAGIC CELL DEATH IN CANCER CELLS
… Receptors (PPARs) (gamma, alpha and delta), PPARgamma is the isoform that is most commonly overexpressed in a plethora of cancer cell types. Cancer-specific overexpression of this nuclear receptor has rendered it an attractive therapeutic target. As such, experimental evidence have accrued in …
-
Differentielle Effekte einer PPARgamma-Aktivierung mit Pioglitazon in der Barrettadenokarzinomzelllinie OE33 in vitro und in vivo
Der intrazelluläre Hormonrezeptor PPARgamma spielt eine Rolle in vielen Differenzierungsprozessen. Zudem konnte in multiplen malignen Tumoren verschiedenen Ursprungsgewebe gezeigt werden, dass sowohl Proliferation als auch Apoptose beeinflusst werden können und so eine neuartige antiproliferative …
-
Obesity-related cardiovascular and metabolic diseases
… study aimed to investigate the role of selective PPARgamma modulation in a sex-specific manner as a future therapeutic intervention for cardiometabolic diseases. We identified a crucial basis for sex-specific PPARgamma modulation in the molecular crosstalk of PPARgamma with estrogen receptors …
-
Macrophage PPAR-Gamma Inhibits Gpr132 to Mediate the Anti-Tumor Effects of Rosiglitazone
… to tumorigenesis. Human cancer is enhanced by PPARgamma loss-of-function mutations, and inhibited by the thiazolidinedione (TZD) class of synthetic PPARgamma agonists and type 2 diabetes drugs such as rosiglitazone. However, it remains enigmatic whether and how macrophage contributes to …
-
THE MECHANISM OF PPARN3-MEDIATED DOWN-REGULATION OF SODIUM HYDROGEN EXCHANGER 1 (NHE1) GENE EPXRESSION AND ITS INHIBITION BY ESTROGEN RECEPTOR N1
Peroxisome proliferator-activated receptor gamma (PPARgamma) has been associated with the process of carcinogenesis, which therefore presents a promising target for cancer treatment. We recently showed that exposure of breast cancer cells to PPARgamma ligands repressed NHE1 expression and …
-
PPAR gamma AND eNOS CONTRIBUTE TO THE RESOLUTION OF CHRONIC INFLAMMATION.
… arthritis the transcription factor, PPARgamma plays a role in the resolution phase. Inhibition of COX-2 activity results in fewer PPARgamma positive cells in the arthritic synovium. Treatment with a PPARgamma antagonist, SR202, alone, also disrupts the process of resolution. PPARgamma …
-
The quantification of total PPARgamma ligand activity in serum samples and the association with adverse metabolic health endpoints
It is well recognized that the global increase in obesity and metabolic diseases over the last several decades cannot be solely attributed to aging and modern lifestyle trends (i.e., excess caloric intake and lack of physical activity). Metabolism disrupting chemicals (MDCs) are environmental and …
-
Peroxisome proliferator-activated receptor (PPAR)-aktivierende Angiotensin Typ 1-Rezeptorblocker bei Adipositas und Insulinresistenz
… HYPOTHESE: Bestimmte ARB wirken als selektive PPARgamma-Modulatoren (SPPARM) und/oder partielle PPARalpha-Agonisten und sind dadurch an der Verbesserung der Insulinsensitivität und/oder des Lipidstoffwechsels beteiligt. METHODEN: Die Regulation des insulinsensitivierenden Fettgewebshormons …
Page 1 of 4